3//SEC Filing
aMoon Growth Fund Limited Partnership 3
Accession 0001178913-23-000318
CIK 0001100397other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 6:37 AM ET
Size
6.5 KB
Accession
0001178913-23-000318
Insider Transaction Report
Form 3
Schindel Yair Chaim
10% Owner
Holdings
- 560,602
Common Stock
aMoon 2 Fund Limited Partnership
10% Owner
Holdings
- 560,602
Common Stock
Footnotes (1)
- [F1]The reported shares are held of record by aMoon Growth Fund, Limited Partnership ("aMoon Growth Fund"). aMoon Growth Fund G.P. Limited Partnership ("aMoon Growth Fund G.P.") is the sole General Partner of aMoon Growth Fund and aMoon General Partner Ltd. ("aMoon General Partner") is the sole General Partner of aMoon Growth Fund G.P. Dr. Yair Schindel is the sole shareholder of aMoon General Partner. By virtue of such relationships, aMoon Growth Fund G.P., aMoon General Partner and Dr. Schindel may be deemed to have shared voting and investment power with respect to the shares held of record by aMoon Growth Fund. Each of aMoon Growth Fund G.P., aMoon General Partner and Dr. Schindel disclaims beneficial ownership of the shares held by aMoon Growth Fund except to the extent of its or his pecuniary interest therein, if any.
Documents
Issuer
Ayala Pharmaceuticals, Inc.
CIK 0001100397
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001744099
Filing Metadata
- Form type
- 3
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 6:37 AM ET
- Size
- 6.5 KB